Proteomics-based strategies to identify proteins relevant to chronic lymphocytic leukemia

Journal of Proteome Research

Volumn 13, Issue 11, 2014, Pages 5051-5062

  Alsagaby, Suliman A ^a,b   Khanna, Sanjay ^a   Hart, Keith W ^a   Pratt, Guy ^c   Fegan, Christopher ^a   Pepper, Christopher ^a   Brewis, Ian A ^a   Brennan, Paul ^a  

^a CARDIFF UNIVERSITY SCHOOL OF MEDICINE   (United Kingdom)

^b MAJMAAH UNIVERSITY   (Saudi Arabia)

^c UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

CLL; iTRAQ based quantitative proteomics; myosin 9; S100A8; TCL 1; TR150

Indexed keywords

CALGRANULIN A; HORMONE RECEPTOR; MYOSIN; MYOSIN 9; PROTEIN; PROTEOME; SYNAPSIN II; T CELL LEUKEMIA LYMPHOMA PROTEIN 1A; THYROID HORMONE RECEPTOR-ASSOCIATED PROTEIN 3; TRANSCRIPTOME; UNCLASSIFIED DRUG; MOLECULAR MOTOR; MYH9 PROTEIN, HUMAN; MYOSIN HEAVY CHAIN; TUMOR MARKER;

ARTICLE; B LYMPHOCYTE; CANCER PROGNOSIS; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; CLUSTER ANALYSIS; COHORT ANALYSIS; CONTROLLED STUDY; GENE EXPRESSION; HIGH RISK PATIENT; HUMAN; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; OUTCOME ASSESSMENT; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEOMICS; TRANSCRIPTOMICS; AGED; BLOOD; FOLLOW UP; KAPLAN MEIER METHOD; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; MASS SPECTROMETRY; METABOLISM; MICROARRAY ANALYSIS; MIDDLE AGED; MORTALITY; PATHOLOGY; PROCEDURES; PROGNOSIS; REPRODUCIBILITY; T CELL LEUKEMIA; TANDEM MASS SPECTROMETRY; VERY ELDERLY;

AGED; AGED, 80 AND OVER; CALGRANULIN A; CLUSTER ANALYSIS; FOLLOW-UP STUDIES; HUMANS; KAPLAN-MEIER ESTIMATE; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; LEUKEMIA, T-CELL; MICROARRAY ANALYSIS; MIDDLE AGED; MOLECULAR MOTOR PROTEINS; MYOSIN HEAVY CHAINS; PROGNOSIS; PROTEINS; PROTEOMICS; REPRODUCIBILITY OF RESULTS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TANDEM MASS SPECTROMETRY; TUMOR MARKERS, BIOLOGICAL;

EID: 84908876279     PISSN: 15353893     EISSN: 15353907     Source Type: Journal    
DOI: 10.1021/pr5002803     Document Type: Article

References (62)

1. Dighiero, G. CLL Biology and Prognosis Hematology 2005, 278-284
2. Rozman, C.; Montserrat, E. Chronic Lymphocytic Leukemia N. Engl. J. Med. 1995, 333, 1052-1057
3. Herishanu, Y.; Polliack, A. Chronic Lymphocytic Leukemia: A Review of Some New Aspects of the Biology, Factors Influencing Prognosis and Therapeutic Options Transfus. Apheresis Sci. 2005, 32, 85-97
4. Allan, J. M.; Sunter, N. J.; Bailey, J. R.; Pettitt, A. R.; Harris, R. J.; Pepper, C.; Fegan, C.; Hall, A. G.; Deignan, L.; Bacon, C. M.; Pointon, J. C.; Houlston, R. S.; Broderick, P.; Mainou-Fowler, T.; Jackson, G. H.; Summerfield, G.; Evans, P. A.; Strefford, J. C.; Parker, A.; Oscier, D.; Pratt, G.; Allsup, D. J. Variant IRF4/MUM1 Associates with CD38 Status and Treatment-Free Survival in Chronic Lymphocytic Leukaemia Leukemia 2010, 24, 877-881
5. Crowther-Swanepoel, D.; Broderick, P.; Di Bernardo, M. C.; Dobbins, S. E.; Torres, M.; Mansouri, M.; Ruiz-Ponte, C.; Enjuanes, A.; Rosenquist, R.; Carracedo, A.; Jurlander, J.; Campo, E.; Juliusson, G.; Montserrat, E.; Smedby, K. E.; Dyer, M. J.; Matutes, E.; Dearden, C.; Sunter, N. J.; Hall, A. G.; Mainou-Fowler, T.; Jackson, G. H.; Summerfield, G.; Harris, R. J.; Pettitt, A. R.; Allsup, D. J.; Bailey, J. R.; Pratt, G.; Pepper, C.; Fegan, C.; Parker, A.; Oscier, D.; Allan, J. M.; Catovsky, D.; Houlston, R. S. Common Variants at 2q37.3, 8q24.21, 15q21.3 and 16q24.1 Influence Chronic Lymphocytic Leukemia Risk Nat. Genet. 2010, 42, 132-136
6. Enjuanes, A.; Benavente, Y.; Bosch, F.; Martin-Guerrero, I.; Colomer, D.; Perez-Alvarez, S.; Reina, O.; Ardanaz, M. T.; Jares, P.; Garcia-Orad, A.; Pujana, M. A.; Montserrat, E.; de Sanjose, S.; Campo, E. Genetic Variants in Apoptosis and Immunoregulation-Related Genes Are Associated with Risk of Chronic Lymphocytic Leukemia Cancer Res. 2008, 68, 10178-10186
7. Pepper, C.; Majid, A.; Lin, T. T.; Hewamana, S.; Pratt, G.; Walewska, R.; Gesk, S.; Siebert, R.; Wagner, S.; Kennedy, B.; Miall, F.; Davis, Z. A.; Tracy, I.; Gardiner, A. C.; Brennan, P.; Hills, R. K.; Dyer, M. J.; Oscier, D.; Fegan, C. Defining the Prognosis of Early Stage Chronic Lymphocytic Leukaemia Patients Br. J. Haematol. 2012, 156, 499-507
8. Hamblin, T. J.; Davis, Z.; Gardiner, A.; Oscier, D. G.; Stevenson, F. K. Unmutated Ig V(H) Genes Are Associated with a More Aggressive Form of Chronic Lymphocytic Leukemia Blood 1999, 94, 1848-1854
9. Damle, R. N.; Wasil, T.; Fais, F.; Ghiotto, F.; Valetto, A.; Allen, S. L.; Buchbinder, A.; Budman, D.; Dittmar, K.; Kolitz, J.; Lichtman, S. M.; Schulman, P.; Vinciguerra, V. P.; Rai, K. R.; Ferrarini, M.; Chiorazzi, N. Ig V Gene Mutation Status and CD38 Expression as Novel Prognostic Indicators in Chronic Lymphocytic Leukemia Blood 1999, 94, 1840-1847
10. Rassenti, L. Z.; Huynh, L.; Toy, T. L.; Chen, L.; Keating, M. J.; Gribben, J. G.; Neuberg, D. S.; Flinn, I. W.; Rai, K. R.; Byrd, J. C.; Kay, N. E.; Greaves, A.; Weiss, A.; Kipps, T. J. ZAP-70 Compared with Immunoglobulin Heavy-Chain Gene Mutation Status as a Predictor of Disease Progression in Chronic Lymphocytic Leukemia N. Engl. J. Med. 2004, 351, 893-901
11. Durig, J.; Naschar, M.; Schmucker, U.; Renzing-Kohler, K.; Holter, T.; Huttmann, A.; Duhrsen, U. CD38 Expression Is an Important Prognostic Marker in Chronic Lymphocytic Leukaemia Leukemia 2002, 16, 30-35
12. Hewamana, S.; Alghazal, S.; Lin, T. T.; Clement, M.; Jenkins, C.; Guzman, M. L.; Jordan, C. T.; Neelakantan, S.; Crooks, P. A.; Burnett, A. K.; Pratt, G.; Fegan, C.; Rowntree, C.; Brennan, P.; Pepper, C. The NF-κB Subunit Rel A Is Associated with in Vitro Survival and Clinical Disease Progression in Chronic Lymphocytic Leukemia and Represents a Promising Therapeutic Target Blood 2008, 111, 4681-4689
13. Otake, Y.; Soundararajan, S.; Sengupta, T. K.; Kio, E. A.; Smith, J. C.; Pineda-Roman, M.; Stuart, R. K.; Spicer, E. K.; Fernandes, D. J. Overexpression of Nucleolin in Chronic Lymphocytic Leukemia Cells Induces Stabilization of BCL2 mRNA Blood 2007, 109, 3069-3075
14. Buggins, A. G.; Pepper, C. J. The Role of Bcl-2 Family Proteins in Chronic Lymphocytic Leukaemia Leuk. Res. 2010, 34, 837-842
15. Boyd, R. S.; Adam, P. J.; Patel, S.; Loader, J. A.; Berry, J.; Redpath, N. T.; Poyser, H. R.; Fletcher, G. C.; Burgess, N. A.; Stamps, A. C.; Hudson, L.; Smith, P.; Griffiths, M.; Willis, T. G.; Karran, E. L.; Oscier, D. G.; Catovsky, D.; Terrett, J. A.; Dyer, M. J. Proteomic Analysis of the Cell-Surface Membrane in Chronic Lymphocytic Leukemia: Identification of Two Novel Proteins, BCNP1 and MIG2B Leukemia 2003, 17, 1605-1612
16. Cochran, D. A.; Evans, C. A.; Blinco, D.; Burthem, J.; Stevenson, F. K.; Gaskell, S. J.; Whetton, A. D. Proteomic Analysis of Chronic Lymphocytic Leukemia Subtypes with Mutated or Unmutated Ig V(H) Genes Mol. Cell Proteomics. 2003, 2, 1331-1341
17. Voss, T.; Ahorn, H.; Haberl, P.; Dohner, H.; Wilgenbus, K. Correlation of Clinical Data with Proteomics Profiles in 24 Patients with B-Cell Chronic Lymphocytic Leukemia Int. J. Cancer 2001, 91, 180-186
18. Perrot, A.; Pionneau, C.; Nadaud, S.; Davi, F.; Leblond, V.; Jacob, F.; Merle-Beral, H.; Herbrecht, R.; Bene, M. C.; Gribben, J. G.; Bahram, S.; Vallat, L. A Unique Proteomic Profile on Surface IgM Ligation in Unmutated Chronic Lymphocytic Leukemia Blood 2011, 118, e1-e15
19. Barnidge, D. R.; Jelinek, D. F.; Muddiman, D. C.; Kay, N. E. Quantitative Protein Expression Analysis of CLL B Cells from Mutated and Unmutated IgV(H) Subgroups Using Acid-Cleavable Isotope-Coded Affinity Tag Reagents J. Proteome Res. 2005, 4, 1310-1317
20. Brennan, P.; Shore, A. M.; Clement, M.; Hewamana, S.; Jones, C. M.; Giles, P.; Fegan, C.; Pepper, C.; Brewis, I. A. Quantitative Nuclear Proteomics Reveals New Phenotypes Altered in Lymphoblastoid Cells Proteomics: Clin. Appl. 2009, 3, 359-369
21. A Language and Environment for Statistical Computing; R Foundation for Statistical Computing: Vienna, Austria, 2013; http://www.R-project.org/.
22. Huttmann, A.; Klein-Hitpass, L.; Thomale, J.; Deenen, R.; Carpinteiro, A.; Nuckel, H.; Ebeling, P.; Fuhrer, A.; Edelmann, J.; Sellmann, L.; Duhrsen, U.; Durig, J. Gene Expression Signatures Separate B-Cell Chronic Lymphocytic Leukaemia Prognostic Subgroups Defined by ZAP-70 and CD38 Expression Status Leukemia 2006, 20, 1774-1782
23. Hutcheson, J.; Scatizzi, J. C.; Siddiqui, A. M.; Haines, G. K., 3rd; Wu, T.; Li, Q. Z.; Davis, L. S.; Mohan, C.; Perlman, H. Combined Deficiency of Proapoptotic Regulators Bim and Fas Results in the Early Onset of Systemic Autoimmunity Immunity 2008, 28, 206-217
24. Billot, K.; Soeur, J. R.; Chereau, F.; Arrouss, I.; Merle-Beral, H. l.; Huang, M.-E.; Mazier, D.; Baud, V. R.; Rebollo, A. Deregulation of Aiolos Expression in Chronic Lymphocytic Leukemia Is Associated with Epigenetic Modifications Blood 2011, 117, 1917-1927
25. Rasheed, S. A.; Teo, C. R.; Beillard, E. J.; Voorhoeve, P. M.; Casey, P. J. MicroRNA-182 and MicroRNA-200a Control G-Protein Subunit α-13 (Gna13) Expression and Cell Invasion Synergistically in Prostate Cancer Cells J. Biol. Chem. 2013, 288, 7986-7995
26. Sherbet, G. V.; Cajone, F. Stathmin in Cell Proliferation and Cancer Progression Cancer Genomics Proteomics 2005, 2, 227-237
27. Price, D. K.; Ball, J. R.; Bahrani-Mostafavi, Z.; Vachris, J. C.; Kaufman, J. S.; Naumann, R. W.; Higgins, R. V.; Hall, J. B. The Phosphoprotein Op18/Stathmin Is Differentially Expressed in Ovarian Cancer Cancer Invest. 2000, 18, 722-730
28. Curmi, P. A.; Nogues, C.; Lachkar, S.; Carelle, N.; Gonthier, M. P.; Sobel, A.; Lidereau, R.; Bieche, I. Overexpression of Stathmin in Breast Carcinomas Points out to Highly Proliferative Tumours Br. J. Cancer. 2000, 82, 142-150
29. Nowakowski, G. S.; Hoyer, J. D.; Shanafelt, T. D.; Geyer, S. M.; LaPlant, B. R.; Call, T. G.; Jelinek, D. F.; Zent, C. S.; Kay, N. E. Using Smudge Cells on Routine Blood Smears to Predict Clinical Outcome in Chronic Lymphocytic Leukemia: A Universally Available Prognostic Test Mayo Clin. Proc. 2007, 82, 449-453
30. Cormier, K. A.; Fournier, S.; OBrien, J.; Tessier, P.; Robichaud, G. A. Role of S100A8 and S100A9 Proteins on Breast Cancer Aggressivity FASEB J. 2009, 23, LB276
31. Hermani, A.; Hess, J.; De Servi, B.; Medunjanin, S.; Grobholz, R.; Trojan, L.; Angel, P.; Mayer, D. Calcium-Binding Proteins S100A8 and S100A9 as Novel Diagnostic Markers in Human Prostate Cancer Clin. Cancer Res. 2005, 11, 5146-5152
32. Bichi, R.; Shinton, S. A.; Martin, E. S.; Koval, A.; Calin, G. A.; Cesari, R.; Russo, G.; Hardy, R. R.; Croce, C. M. Human Chronic Lymphocytic Leukemia Modeled in Mouse by Targeted TCL1 Expression Proc. Natl. Acad. Sci. U.S.A. 2002, 99, 6955-6960
33. Balan, V.; Nangia-Makker, P.; Raz, A. Galectins as Cancer Biomarkers Cancers 2010, 2, 592-610
34. Golan-Gerstl, R.; Cohen, M.; Shilo, A.; Suh, S. S.; Bakcs, A.; Coppola, L.; Karni, R. Splicing Factor HNRNP A2/B1 Regulates Tumor Suppressor Gene Splicing and Is an Oncogenic Driver in Glioblastoma Cancer Res. 2011, 71, 4464-4472
35. Gebhardt, C.; Nmeth, J.; Angel, P.; Hess, J. S100A8 and S100A9 in Inflammation and Cancer Biochem. Pharmacol. 2006, 72, 1622-1631
36. Vogl, T.; Gharibyan, A. L.; Morozova-Roche, L. A. Pro-Inflammatory S100A8 and S100A9 Proteins: Self-Assembly into Multifunctional Native and Amyloid Complexes Int. J. Mol. Sci. 2012, 13, 2893-2917
37. Barnidge, D. R.; Tschumper, R. C.; Jelinek, D. F.; Muddiman, D. C.; Kay, N. E. Protein Expression Profiling of CLL B Cells Using Replicate Off-Line Strong Cation Exchange Chromatography and LC-MS/MS J. Chromatogr. B: Anal. Technol. Biomed. Life Sci. 2005, 819, 33-39
38. Grunewald, T. G.; Kammerer, U.; Kapp, M.; Eck, M.; Dietl, J.; Butt, E.; Honig, A. Nuclear Localization and Cytosolic Overexpression of LASP-1 Correlates with Tumor Size and Nodal-Positivity of Human Breast Carcinoma BMC Cancer 2007, 7, 198-207
39. Fondell, J. D.; Ge, H.; Roeder, R. G. Ligand Induction of a Transcriptionally Active Thyroid Hormone Receptor Coactivator Complex Proc. Natl. Acad. Sci. U.S.A. 1996, 93, 8329-8333
40. Lee, K.-M.; Hsu, I.-W.; Tarn, W.-Y. TRAP150 Activates Pre-mRNA Splicing and Promotes Nuclear mRNA Degradation Nucleic Acids Res. 2010, 38, 3340-3350
41. Bracken, C. P.; Wall, S. J.; Barre, B.; Panov, K. I.; Ajuh, P. M.; Perkins, N. D. Regulation of Cyclin D1 RNA Stability by Snip1 Cancer Res. 2008, 68, 7621-7628
42. Jain, P.; Giustolisi, G. M.; Atkinson, S.; Elnenaei, M. O.; Morilla, R.; Owusu-Ankomah, K.; Rafiq-Mohammed, F.; Matutes, E.; Wotherspoon, A.; Catovsky, D. Detection of Cyclin D1 in B Cell Lymphoproliferative Disorders by Flow Cytometry J. Clin. Pathol. 2002, 55, 940-945
43. Abboudi, Z.; Patel, K.; Naresh, K. N. Cyclin D1 Expression in Typical Chronic Lymphocytic Leukaemia Eur. J. Haematol. 2009, 83, 203-207
44. Hermani, A.; De Servi, B.; Medunjanin, S.; Tessier, P. A.; Mayer, D. S100A8 and S100A9 Activate MAP Kinase and NF-κB Signaling Pathways and Trigger Translocation of Rage in Human Prostate Cancer Cells Exp. Cell Res. 2006, 312, 184-197
45. Cross, S. S.; Hamdy, F. C.; Deloulme, J. C.; Rehman, I. Expression of S100 Proteins in Normal Human Tissues and Common Cancers Using Tissue Microarrays: S100A6, S100A8, S100A9 and S100A11 Are All Overexpressed in Common Cancers Histopathology 2005, 46, 256-269
46. Salama, I.; Malone, P. S.; Mihaimeed, F.; Jones, J. L. A Review of the S100 Proteins in Cancer Eur. J. Surg. Oncol. 2008, 34, 357-364
47. - Sub-Clones Derived from the Same Chronic Lymphocytic Leukemia Patient Have Distinct Gene Expression Signatures Despite Their Monoclonal Origin Leukemia 2007, 21, 687-696
48. Benedyk, M.; Sopalla, C.; Nacken, W.; Bode, G.; Melkonyan, H.; Banfi, B.; Kerkhoff, C. HaCaT Keratinocytes Overexpressing the S100 Proteins S100A8 and S100A9 Show Increased NADPH Oxidase and NF-κB Activities J. Invest. Dermatol. 2007, 127, 2001-2011
49. Hewamana, S.; Lin, T. T.; Rowntree, C.; Karunanithi, K.; Pratt, G.; Hills, R.; Fegan, C.; Brennan, P.; Pepper, C. Rel A Is an Independent Biomarker of Clinical Outcome in Chronic Lymphocytic Leukemia J. Clin. Oncol. 2009, 27, 763-769
50. Gaudio, E.; Spizzo, R.; Paduano, F.; Luo, Z.; Efanov, A.; Palamarchuk, A.; Leber, A. S.; Kaou, M.; Zanesi, N.; Bottoni, A.; Costinean, S.; Rassenti, L. Z.; Nakamura, T.; Kipps, T. J.; Aqeilan, R. I.; Pekarsky, Y.; Trapasso, F.; Croce, C. M. TCL1 Interacts with ATM and Enhances Nf-κB Activation in Hematologic Malignancies Blood 2012, 119, 180-187
51. Palamarchuk, A.; Yan, P. S.; Zanesi, N.; Wang, L.; Rodrigues, B.; Murphy, M.; Balatti, V.; Bottoni, A.; Nazaryan, N.; Alder, H.; Rassenti, L.; Kipps, T. J.; Freitas, M.; Croce, C. M.; Pekarsky, Y. TCL1 Protein Functions as an Inhibitor of De Novo DNA Methylation in B-Cell Chronic Lymphocytic Leukemia (CLL) Proc. Natl. Acad. Sci. U.S.A. 2012, 109, 2555-2560
52. Herling, M.; Patel, K. A.; Khalili, J.; Schlette, E.; Kobayashi, R.; Medeiros, L. J.; Jones, D. TCL1 Shows a Regulated Expression Pattern in Chronic Lymphocytic Leukemia That Correlates with Molecular Subtypes and Proliferative State Leukemia 2006, 20, 280-285
53. Mansouri, M. R.; Sevov, M.; Aleskog, A.; Jondal, M.; Merup, M.; Sundstrom, C.; Osorio, L.; Rosenquist, R. IGHV3-21 Gene Usage Is Associated with High TCL1 Expression in Chronic Lymphocytic Leukemia Eur. J. Haematol. 2010, 84, 109-116
54. Morin, N. A.; Oakes, P. W.; Hyun, Y. M.; Lee, D.; Chin, Y. E.; King, M. R.; Springer, T. A.; Shimaoka, M.; Tang, J. X.; Reichner, J. S.; Kim, M. Nonmuscle Myosin Heavy Chain IIA Mediates Integrin LFA-1 De-adhesion During T Lymphocyte Migration J. Exp. Med. 2008, 205, 195-205
55. Smith, A.; Bracke, M.; Leitinger, B.; Porter, J. C.; Hogg, N. LFA-1-Induced T Cell Migration on ICAM-1 Involves Regulation of MLCK-Mediated Attachment and ROCK-Dependent Detachment J. Cell Sci. 2003, 116, 3123-3133
56. Jacobelli, J.; Friedman, R. S.; Conti, M. A.; Lennon-Dumenil, A. M.; Piel, M.; Sorensen, C. M.; Adelstein, R. S.; Krummel, M. F. Confinement-Optimized Three-Dimensional T Cell Amoeboid Motility Is Modulated Via Myosin IIA-Regulated Adhesions Nat. Immunol. 2010, 11, 953-961
57. Clark, R. A.; Fuhlbrigge, R. C.; Springer, T. A. L-Selectin Ligands That Are O-Glycoprotease Resistant and Distinct from MECA-79 Antigen Are Sufficient for Tethering and Rolling of Lymphocytes on Human High Endothelial Venules J. Cell Biol. 1998, 140, 721-731
58. Deaglio, S.; Vaisitti, T.; Bergui, L.; Bonello, L.; Horenstein, A. L.; Tamagnone, L.; Boumsell, L.; Malavasi, F. CD38 and CD100 Lead a Network of Surface Receptors Relaying Positive Signals for B-CLL Growth and Survival Blood 2005, 105, 3042-3050
59. Deaglio, S.; Aydin, S.; Grand, M. M.; Vaisitti, T.; Bergui, L.; DArena, G.; Chiorino, G.; Malavasi, F. CD38/CD31 Interactions Activate Genetic Pathways Leading to Proliferation and Migration in Chronic Lymphocytic Leukemia Cells Mol. Med. 2010, 16, 87-91
60. Matsuda, A.; Suzuki, Y.; Honda, G.; Muramatsu, S.; Matsuzaki, O.; Nagano, Y.; Doi, T.; Shimotohno, K.; Harada, T.; Nishida, E.; Hayashi, H.; Sugano, S. Large-Scale Identification and Characterization of Human Genes That Activate NF-κB and MAPK Signaling Pathways Oncogene 2003, 22, 3307-3318
61. Cao, W.; Liu, N.; Tang, S.; Bao, L.; Shen, L.; Yuan, H.; Zhao, X.; Lu, H. Acetyl-Coenzyme a Acyltransferase 2 Attenuates the Apoptotic Effects of BNIP3 in Two Human Cell Lines Biochim. Biophys. Acta 2008, 1780, 873-880
62. Sahara, S.; Aoto, M.; Eguchi, Y.; Imamoto, N.; Yoneda, Y.; Tsujimoto, Y. Acinus Is a Caspase-3-Activated Protein Required for Apoptotic Chromatin Condensation Nature 1999, 401, 168-173